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Arylamine-DNA Adducts In Vitro and
In Vivo: Their Role in Bacterial
Mutagenesis and Urinary Bladder
Carcinogenesis
by Frederick A. Beland,* David T. Beranek,*
Kenneth L. Dooley,* Robert H. Heflich* and
Fred F. Kadlubar*
Hepatic N-oxidation, followed by N-glucuronidation, has been proposed as a route of metabolic ac-
tivation for arylamine bladder carcinogens. It is postulated that theN-glucuronides are transported
to the bladder lumen where they are hydrolyzed under slightly acidic conditions to release direct-
acting carcinogenic and mutagenic N-hydroxyarylamines. In this study, 4-aminobiphenyl (ABP), 1-
naphthylamine (1-NA), 2-naphthylamine (2-NA), 2-acetylaminofluorene (AAF), 4-nitrobiphenyl (NBP),
benzidine (BZ), and N-acetylbenzidine (ABZ) were administered to male beagle dogs (60 mmole/kg),
and the bladder epithelium DNA adducts were quantified at various times after treatment. At 24-48
hr after administration, the order of binding to bladder epithelium DNA was: ABP >> AAF >
NBP 2-NA-BZ ABZ>> 1-NA. The level of DNA modification by ABP remained constant for 7
days, whereas 2-NA and AAF residues decreased by 35% and 80%, respectively. The extent and
relative persistence of total DNA binding correlated with the compounds' ability to induce bladder
tumors in dogs. ABP, AAF, NBP, 2-NA and ABZ administration resulted in DNA binding sufficient
for adduct analysis. Enzymatic hydrolysis of the DNA and examination of the adducts by high
pressure liquid chromatography indicated that arylamine substitution at C8 of deoxyguanosine was
the dominant product. Additional adducts were detected in animals treated with ABP, NBP, and 2-
NA. Furthermore, the profiles of adducts obtained in vivo were remarkably similar to the profiles
obtained when theN-hydroxy arylamine metabolites of these carcinogens were reacted with DNA in
vitro at pH 5.0. To evaluate the mutagenic potential of these arylamine-DNA adducts, Salmonella
typhimurium strains TA 1535 and TA 1538 were incubated with N-hydroxy-2-NA, N-hydroxy-2-
aminofluorene (AF), N-hydroxy-ABP, and N-hydroxy-ABZ and the resulting DNA adducts and
reversions were quantified. Arylamine-C8-deoxyguanosine substitution was correlated with
frameshift reversions induced by these agents, with the lesions showing a relative order of mu-
tagenic efficiency of ABZ>AF-2-NA>ABP. These data suggest that mutagenic N-hydroxyaryl-
amines may be ultimate carcinogens for the bladder epithelium. Furthermore, if one assumes that a
mutagenic lesion is important for tumor initiation, then C8-deoxyguanosine substitution by these
compounds may be significant for urinary bladder carcinogenesis.
Introduction
In 1895, the German physician Rehn noted a rela-
tionship between workers exposed to aromatic
amines and the incidence of bladder cancer (1). Al-
though he named this disease "aniline cancer," sub-
sequent studies indicated that the tumors were ac-
tually caused by 2-naphthylamine. During the inter-
vening years, industrial exposure to other aromatic
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amines, such as benzidine and 4-aminobiphenyl, has
also been associated with an increased risk to
bladder cancer (2-4).
Man is not the only species susceptible to bladder
tumorigenesis following exposure to aromatic
amines. Mice, rats, guinea pigs, hamsters, and
rabbits are also sensitive; however, it is the dog
that most closely parallels man's response to these
chemicals (3, 5). From the studies of McDonald and
Lund (6) and Scott and Boyd (7), it became apparent
that an agent contained in the urine of dogs ex-
posed to arylamines was responsible for tumorBELAND ETAL.
induction. Based on these data and others, various
models for bladder tumor formation have been
developed. One model suggests that in the liver
there is a critical balance between N-acetylation
followed by N-oxidation versus initial N-oxidation
and subsequent N-glucuronidation (8-10). Species,
such as the rat, which favor the former pathway,
appear to preferentially develop liver tumors, while
the bladder is the primary target site in animals for
which the latter pathway predominates. As noted
by Poirier et al. (11) and Lower and Bryan (12), dogs
do not N-acetylate aromatic amines very well and,
according to this model, should be quite susceptible
to induction of bladder tumors. Humans, in contrast,
show considerable genetic variability in their ability
toN-acetylate arylamines (13), and this variation has
been implicated in the etiology of aromatic amine-in-
duced bladder tumors (9, 14).
According to the model, the N-glucuronidation of
N-hydroxyarylamines serve to transport the carcin-
ogen to the bladder (8, 10). These polar metabolites
are quite stable at neutral pH; however, under
slightly acidic conditions, they rapidly hydrolyze to
the unconjugated N-hydroxyarylamines (8). The im-
portance of urinary pH in the formation of these N-
hydroxy metabolites has recently been demon-
strated in rats treated with 2-naphthylamine (15).
Rats normally have a urinary pH of 6.7 but by sup-
plementation of their drinking water with either
ammonium chloride or sodium bicarbonate, the pH
of the urine was altered to 5.7 and 7.7, respectively.
Although the total amount of urinary N-hydroxyl-
ated metabolites (free and N-glucuronidated)
remained constant, as the pH became more acidic,
the amount of free N-hydroxy-2-naphthylamine
increased transformation frequency resulted when
have acidic urine (8, 16), this acidity could facilitate
the hydrolysis ofN-hydroxy-N-glucuronides toN-hy-
droxyarylamines thus increasing their susceptibility
to arylamine-induced bladder tumors.
The covalent interaction of carcinogens with
DNA is considered to be an essential step in the ini-
tiation of tumors. N-Hydroxyarylamines readily re-
act with DNA at slightly acidic pH (8, 17) and are di-
rectly mutagenic (18, 19) and carcinogenic (8). Fur-
thermore, a recent study (20) demonstrated that an
increased transformation frequently resulted when
diploid human fibroblasts were incubated with
either N-hydroxy-1-naphthylamine or N-hydroxy-2-
naphthylamine at pH 5 compared to pH 7. Since the
pH-dependent model predicts that N-hydroxyaryl-
amines are the ultimate carcinogenic species in
bladder tumor induction, the products formed in vi-
tro from reacting N-hydroxyarylamines with DNA
should correspond directly with the adducts formed
in vivo in dogs administered the parent arylamines.
To investigate this concept, we have embarked
upon studies to compare the adducts in both of
these systems. In addition, we have attempted to
assess the biological potential of individual DNA ad-
ducts by using a Salmonella typhimurium muta-
tional assay.
Materials and Methods
The 4-aminobiphenyl-DNA adducts were pre-
pared as previously described (21). The adducts
were isolated by high pressure liquid chromatogra-
phy and characterized by 'H nuclear magnetic reso-
nance and electron impact in-beam desorption mass
spectroscopy (22) with Bruker WM 500 and Finni-
gan 4023 instruments, respectively. Before mass
spectral analysis, the samples were treated with N-
methyl-N-trimethylsilyl trifluoroacetamide:dimethyl-
formamide (1:1) at 370C for 30 min. Additional
confirmation of adduct structure was provided from
pH-dependent partitioning experiments (23) with
5% n-butanol in diethyl ether as the organic phase
and 50 mMbuffers of the appropriate pH.
Male beagle dogs (8-10 kg; Marshall Lab Animals,
North Rose, NY) were treated PO with 3H-carcino-
gens in gelatin capsules (60 jmole/kg; 170-1220
mCi/mmole; obtained from Robert Roth, Midwest
Research Institute, Kansas City, MO) and were
killed at selected intervals by Nembutal injection.
Hepatic and bladder epithelium arylamine-modified
DNA were isolated by solvent extraction and hy-
droxylapatite chromatography (24). In some in-
stances, the DNA was further purified by cesium
chloride centrifugation (25). Acetylaminofluorene-
modified DNA was enzymatically digested with
DNase I (Sigma), phosphodiesterase (Sigma) and al-
kaline phosphatase (Sigma; Ref. 26). Benzidine- and
N-acetylbenzidine-modified DNA were hydrolyzed
with DNase I, nuclease P1 (Calbiochem-Behring), and
acid and alkaline phosphatase (Sigma) (27).
Mutagenicity experiments were conducted by
use ofSalmonella typhimurwium strains TA 1535 and
TA 1538 (obtained from B.N. Ames, University of
California, Berkeley, CA) as previously described
(21, 28).
Results and Discussion
In Vitro Reaction ofN-Hydroxyarylamines
with DNA
N-Hydroxyarylamines readily react with biologi-
cal macromolecules. With nucleic acids, this process
is acid-catalyzed with binding increasing approxi-
mately 5-fold for each unit decrease between pH 7
and 5 (8, 27, 29, 30). In contrast, protein binding does
not appear to be pH-dependent, because incubations
conducted between pH 5 and 7 show equivalent re-
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activity (8, 27, 29, 30). This is apparently due to auto-
oxidation of N-hydroxyarylamines under neutral
conditions to nitrosoarenes which also bind to pro-
tein (29,30).
The first structural identification of N-hydroxy-
arylamine-nucleic acid adducts were conducted by
Kriek (17) and by King and Phillips (31), who
proposed that covalent linkage should occur be-
tween C8 of deoxyguanosine and the arylamine ni-
trogen ofN-hydroxyaminofluorene. This assignment
has recently been confirmed through the use of nu-
clear magnetic resonance spectroscopic techniques
(26). In addition, Kriek and Westra have demon-
strated that this C8-deoxyguanosine adduct is alkali-
labile and will undergo hydrolysis at slightly alka-
line pH to yield an imidazole ring-opened adduct
(32). To date, the only other N-hydroxyarylamine
that appears to give exclusively C8-deoxyguanosine
substitution is N-hydroxy-N'-acetylbenzidine (27).
The adduct profiles obtained from reacting N-
hydroxyarylamines with DNA in vitro at acidic pH
are summarized in Figure 1. WhileN-hydroxy-2-ami-
nofluorene and N-hydroxy-N'-acetylbenzidine gave
exclusively C8-deoxyguanosine adducts, the otherN-
hydroxyarylamines yielded a mixture of products.
With N-hydroxy-2-naphthylamine (30), C8-deoxygua-
nosine substitution also predominated; however, in
this case it appeared to exist primarily in an imidaz-
ole ring-opened configuration. Two other minor N-
hydroxy-2-naphthylamine adducts have been charac-
terized as 1-deoxyguanosin-N2-yl-2-naphthylamine
and 1-(deoxyadenosin-N6-yl)-2-naphthylamine which
represented 30% and 15% of the total binding,
respectively. The isomeric N-hydroxy derivative, N-
hydroxy-1-naphthylamine, is unique among aryl-
amines because two of the adducts that have been
characterized are bound through 06 of deoxyguano-
sine, with the major substitution (60%) occurring
through the arylamine nitrogen and 30% of the
binding through the ortho carbon (29). In a recent
report (33), evidence for C8-deoxyguanosine substi-
tution was presented, but we have been unable to
confirm this observation.
When N-hydroxy-4-aminobiphenyl was reacted
with DNA at pH 5, three DNA adducts resulted.
We have previously identified the major product,
which accounted for 80% of the total binding, as N-
(deoxyguanosin-8yl)4-aminobiphenyl (21). A second
adduct, which represented 15% of the binding, was
unambiguously characterized as a novel C8-deoxy-
adenosine product and a third adduct (5%) was
tentatively assigned as an additional deoxyadeno-
sine product. Additional studies have failed to con-
firm this latter structure; instead, the data strongly
indicated that the minor adduct was N-deoxyguano-
sin-N2-yl)4-aminobiphenyl. Following silyation, in-
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FIGURE 1. Percent distribution of arylamine-DNA adducts
formed from N-hydroxyarylamines in vitro. The N-hy-
droxyarylamine derivatives of 2-aminofluorene (AF), N-
acetylbenzidine (ABZ), 4-aminobiphenyl (4-ABP), 2-naph-
thylamine (2-NA) and 1-naphthylamine (1-NA) were incu-
bated with calf thymus DNA at acidic pH. Individual
adducts were quantified after enzymatic hydrolysis and
separation by high pressure liquid chromatography. The
site of substitution on the purine base is indicated by the
base modified followed by the atom substituted. For
example, dG-C8 indicates substitution at carbon 8 of
deoxyguanosine.
beam electron impact mass spectral analysis (22)
gave a molecular ion at m/z 795 which was con-
sistent with a penta(trimethylsilyl)deoxyguanosine
adduct. 'H nuclear magnetic resonance spectra of
this minor adduct indicated the presence of all nine
aromatic protons associated with the biphenyl
rings. Resonances were also detected that could be
assigned to H8 and Hi of deoxyguanosine, plus two
additional signals that were ascribed to a novel
hydrazo linkage. Finally, the adduct had both acidic
and basic pka's, as determined by pH-dependent
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partitioning experiments (23), which was consistent
with the proposed deoxyguanosine substitution.
In Vivo Arylamine-DNA Adducts
Male beagle dogs were treated with [3H] carcino-
gens at a dose of 60 ,imole/kg body weight and then
were killed after 1, 2, or 7 days. Liver and bladder
epithelium DNAs were isolated and enzymatically
hydrolyzed to mononucleosides. The adducts were
then identified through high pressure liquid chro-
matographic comparison to standards synthesized
by reacting the respective N-hydroxyarylamine
with DNA at acidic pH. In instances where there
was sufficient radioactivity, the identity of the in-
dividual adducts was confirmed through application
of the pH-dependent partitioning technique of
Moore and Koreeda (23).
The results from the bladder epithelium DNA
binding studies are shown in Figure 2a. The most
extensive binding was detected with 4-aminobiphe-
nyl, which correlated with it being the most potent
bladder carcinogen investigated (34). The con-
centration of adducts was essentially constant at
each time point with N-deoxyguanosin-8-yl)4-amino-
biphenyl accounting for 76% of the total binding. In
contrast to what was found when N-hydroxy-4-ami-
nobiphenyl was reacted with DNA in vitro (Fig. 1),
the next most abundant in vivo product was the N-2-
deoxyguanosine substituted adduct (15%). The
remainder of the DNA binding (9%) was identified
as beingN-(deoxyadenosin-8-yl)4-aminobiphenyl.
The nitrated analog, 4-nitrobiphenyl, gave a simi-
lar profile of adducts, although the extent of binding
was only 5% of that observed with 4-aminobiphe-
nyl. These data suggest that 4-nitrobiphenyl is, to a
limited extent, metabolically activated through N-
hydroxyarylamine formation. This reduction could
occur in the liver, or alternatively, intestinal micro-
flora may reduce the nitro moiety to an amine and
subsequent hepatic oxidation could then result in N-
hydroxyarylamine formation. In support of this lat-
ter pathway, anaerobic intestinal bacteria have re-
cently been implicated in the metabolic activation of
2,4-dinitrotoluene (35) and an in vitro culture of rat
intestinal bacteria has been shown to reduce 1-nitro-
pyrene to its corresponding amine (36). The much
lower binding of 4-nitrobiphenyl compared to 4-
aminobiphenyl correlated with its weak carcinogeni-
city in the dog bladder (34).
The carcinogenic amide, 2-acetylaminofluorene,
also gave a much lower binding to bladder epitheli-
um DNA than was observed with 4-aminobiphenyl.
Only one adduct was detected and this was identical
to the product obtained whenN-hydroxy-2-aminoflu-
orene was incubated with DNA. The formation of
this nonacetylated adduct is consistent with the
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FIGURE 2. Extent of arylamine DNA adduct formation in (a)
bladder epithelium, and (b) liver of dogs administered 4-
aminobiphenyl (4-ABP), 2-acetylaminofluorene (2-AAF), N-
acetylbenzidine (ABZ), benzidine (BZ), 4-nitrobiphenyl (4-
NBP), 2-naphthylamine (2-NA) and 1-naphthylamine (1-
NA). The hatched area refers to substitution at C8 of
deoxyguanosine, while the open area indicates substitution
at other atoms on purine bases. The dogs were sacrificed
on the day indicated at the top of the histogram. The
carcinogenicity data are from the literature (34, 38). The
data for benzidine, marked by an asterisk (*), is an ex-
trapolated value based upon approximations discussed in
text.
ability of dog liver to deacetylate 2-acetylaminofluo-
rene (9). As opposed to what was observed with the
aminobiphenyl adducts, the concentration of N-
(deoxyguanosin-8-yl)2-aminofluorene decreased by
80% from 2 through 7 days. Whether this decrease
is due to cell turnover as a result of cellular toxicity
or DNA repair remains to be determined.
As previously reported, 2-naphthylamine caused
the formation of three adducts at a total binding
similar to that of 4-nitrobiphenyl (21, 37). The major
DNA product was, again, a C8-substituted deoxygua-
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nosine which accounted for 48% of the total DNA
adducts, but there were also substantial quantities
(36%) of N(deoxyadenosin-N-yl-2-naphthylamine.
The remaining adduct detected was identical to the
NM-deoxyguanosine product formed in vitro from re-
acting N-hydroxy-2-naphthylamine with DNA. Ex-
amination of the bladder epithelium DNA 7 days fol-
lowing treatment revealed a 33% decrease in ac-
tivity. This reduction was due primarily to a loss of
N-(deoxyadenosin-NM-yl)2-naphthylamine. This sug-
gests that bladder epithelial cells may be able to
excise preferentially specific DNA adducts.
When bladder epithelium DNA from a dog
treated with 1-naphthylamine was examined, bind-
ing could not be detected (37). (The limit of sen-
sitivity was approximately 1 adduct/108 nucleotides.)
The failure to find binding corresponds to the lack
of carcinogenicity for this compound (38). Radioac-
tivity could be detected in bladder epithelium DNA
of a dog treated with [3H]-benzidine; however, due
to its low specific activity, benzidine binding was of
an insufficient magnitude to perform adduct
analysis. If it is assumed there is only one product
formed (cf., liver and N-acetylbenzidine-treated dog),
then based upon typical recoveries during en-
zymatic hydrolysis, the binding would not exceed 30
residues/108 nucleotides, a level similar to 2-
naphthylamine and 4-nitrobiphenyl. Another dog
was treated with N-acetylbenzidine, and in contrast
to benzidine, a high level of radioactivity was
associated with the bladder epithelial DNA.
However, upon enzymatic hydrolysis, only 10% of
the radioactivity partitioned into n-butanol, as
compared to >70% for the other carcinogens
studied. Examination of the n-butanol-soluble
fraction revealed primarily one product which
coeluted with N-deoxyguanosin-8-yl)N'-acetylbenzi-
dine at a binding level that approximated that
observed with the benzidine-treated dog. The radio-
activity that did not partition into the n-butanol
may represent protein-benzidine-DNA crosslinking
as has b en reported for N-acetoxy-2-acetylami-
nofluorene by Metzger and Werbin (39).
In addition to examining the bladder epithelium
DNA, liver DNA from each dog was analyzed (Fig.
2b). Of the carcinogens administered, only 2-acetyl-
aminofluorene has been reported to be hepatocar-
cinogenic in this species (40). The only hepatic DNA
adduct identified following 2-acetylaminofluorene
treatment was N-deoxyguanosin-8yl)2-aminofluo-
rene. Since N,O-acyltransferase has not been de-
tected in dog liver (41), this suggests that the elec-
trophilic species is N-hydroxy-2-aminofluorene. [We
previously reported the presence of low levels of
the acetylated adducts 34(deoxyguanosin-N-yl)2-ace-
tylaminofluorene and NAdeoxyguanosin-8yl)2-ace-
tylaminofluorene (21). However, pH-partitioning ex-
periments indicate that the small quantities of ra-
dioactivity that coelute with these markers are not
due to these adducts.] Qualitatively, the spectrum of
adducts observed in hepatic DNA from each carcin-
ogen was similar to that detected in the bladder epi-
thelium. There were, however, quantitative differ-
ences. The binding of 2-acetylaminofluorene was
seven times as high in the liver as in the bladder. 4-
Aminobiphenyl gave similar adduct concentrations
in both tissues, and 2-naphthylamine and 4-nitrobi-
phenyl had more extensive adduct formation in the
bladder. The benzidine- and N-acetylbenzidine-
treated dogs had very high levels of radioactivity
associated with hepatic DNA. However, after enzy-
matic hydrolysis, <1% of the radioactivity parti-
tioned into n-butanol and the only adduct detected
was N-(deoxyguanosin-8-yl-N'-acetylbenzidine. Since
both benzidine and N-acetylbenzidine give the same
adduct and the same level of binding, this indicates
that there is an equilibrium between acetylation
and deacetylation with deacetylation greatly fa-
vored. Since individuals who have been exposed to
benzidine-based azo dyes have been reported to
excrete substantial quantities of N-acetylbenzidine
(42), these data suggest either that the dog is a poor
model or that it seriously underestimates the
potential risk of benzidine exposure in man.
As was observed in the bladder, the DNA ad-
ducts obtained from 2-naphthylamine- and 2-acetyl-
aminofluorene-treated dogs decreased in con-
centration from 2 through 7 days. With 2-acetylami-
nofluorene, there was an 80% loss of N-deoxygua-
nosin-8-yl)2-aminofluorene, while with 2-naphthyl-
amine, both the C8-substituted deoxyguanosine and
NM-substituted deoxyadenosine adducts decreased in
concentration. Interestingly, the concentration of
the 4-aminobiphenyl adducts remained constant
with time and, although the binding of this aryl-
amine to hepatic DNA was similar to the level ob-
served with 2-acetylaminofluorene, 4-aminobiphenyl
is not a hepatocarcinogen for the dog. This observa-
tion suggests that there may be fundamental differ-
ences in the biological activity of various arylamine
DNA adducts.
Reversions and DNA Adducts Induced by
N-Hydroxyarylamines inSalmonella
typhimurium
To assess the relationship between arylamine-
DNA adducts and mutation induction, the N-
hydroxyarylamines were incubated with Salmonella
typhimurium strains TA 1538 and TA 1535. After a
30-min exposure, aliquots were analyzed for both
induced reversions and bacterial survival, while the
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remainder of the bacteria were used for DNA-
adduct determination.
Figure 3 illustrates mutation frequency and bac-
terial survival as a function of dose in strain TA
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FIGURE 3. Revertants/105 surviving bacteria and percent sur-
vival of Salmonella typhimurium TA 1538 exposed to dif-
ferent concentrations of theN-hydroxyarylamines of 2-ami-
nofluorene (2-AF), 4-aminobiphenyl (4-ABP), 2-naphthyl-
amine (2-NA) and N-acetylbenzidine (ABZ).
1538. N-Hydroxy-2-aminofluorene was the most mu-
tagenic and the second most cytotoxic (as indicated
by percent survival) compound studied. N-Hydroxy-
2-naphthylamine was the most toxic of these agents
but was only weakly mutagenic, while N-hydroxy-
N'-acetylbenzidine was quite mutagenic and only
slightly cytotoxic. Thus, there does not appear to be
an obvious relationship between cytotoxicity and
reversions induced by these compounds in strain
TA 1538.
The variation in mutagenicity between the N-hy-
droxyarylamines could reflect differences in the
extent of reaction of the compounds with bacterial
DNA, or, alternatively, it may indicate that some
lesions were more efficient in inducing frameshift
reversions than others. To differentiate between
these possibilities, the bacterial DNA was isolated
and the extent of binding and the adduct profile
were established. Figure 4 illustrates revertants as
a function of total binding. While N-hydroxy-N'-
acetylbenzidine demonstrated intermediate mutage-
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FIGURE 4. Comparison of the revertants/105 survivors versus
arylamine residues/105 nucleotides for Salmonella typhi-
murium TA 1538 incubated with N-hydroxyarylamines.
See Figure 3 for abbreviations used.
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nicity when plotted as a function of dose, it was
clearly the most mutagenic N-hydroxyarylamine in
strain TA 1538 when expressed as a function of
total binding. This was followed by N-hydroxy-2-
aminofluorene and then N-hydroxy-2-naphthylamine
and N-hydroxy4-aminobiphenyl which showed ap-
proximately the same number of revertants per
bound residue.
High pressure liquid chromatographic analysis of
the enzymatic hydrolyzate of the bacterial DNA
indicated that only C8-deoxyguanosine adducts were
formed from N-hydroxy-N'-acetylbenzidine and N-
hydroxy-2-aminofluorene (Fig. 5). This suggests that
the frameshift reversions detected by strain TA
1538 are due to substitution at this position. The
other two compounds gave the same mixture of
adducts that was observed in vitro; however, N-
hydroxy-2-naphthylamine gave substantially less C8-
deoxyguanosine substitution and correspondingly
more of the N2-deoxyguanosine adduct. When
frameshift revertants are expressed as a function
of C8-deoxyguanosine substitution, the following
trends become evident (Fig. 6). The adduct resulting
from N-hydroxy-N'-acetylbenzidine is clearly the
most mutagenic lesion and causes approximately
five times as many revertants per bound residue as
N-deoxyguanosin-8-yl-2-aminofluorene. Similarly,
the C8 adduct formed from N-hydroxy-2-aminofluo-
rene is much more efficient at inducing mutations
than the analogous lesion from N-hydroxy-4-amino-
biphenyl. The analysis of N-hydroxy-2-naphthyl-
amine was complicated by its high toxicity and low
mutagenicity in strain TA 1538. However, when
revertants are expressed as a function of C8-deoxy-
guanosine substitution, it has a mutagenic efficiency
similar to N-hydroxy-2-aminofluorene. It should be
noted that if other adducts formed from N-hydroxy-
2-naphthylamine or N-hydroxy-4-aminobiphenyl are
also involved in frameshift reversion induction, then
the mutagenic efficiency of the C8-deoxyguanosine
adducts produced by these agents would be lower.
The reason for the variations in mutation induction
is not known but may be due to differences in the
ability of the adducts to adopt a syn conformation
about the glycosyl bond (43).
Similar incubations were conducted with strain
TA 1535 which detects base-substitution reversions.
In this strain, N-hydroxy-2-aminofluorene was the
most toxic compound, but did not induce any
reversions (Fig. 7). This observation reinforces the
concept that, at least in Salmonella typhimurium,
there is not a direct relationship between toxicity
and mutagenicity. The only compound that induced
reversions in strain TA 1535 was N-hydroxy-2-naph-
thylamine. The fact that N-hydroxy-2-aminofluorene
and N-hydroxy-N'-acetylbenzidine were not muta-
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FIGURE 5. Percent distribution of arylamine adducts in Sal-
monella typhimurium DNA from bacteria incubated with
the N-hydroxyarylamine of N-acetylbenzidine, 2-aminofluo-
rene, 4-aminobiphenyl and 2-naphthylamine. See Figure 3
for abbreviations used.
genic, suggests that C8-deoxyguanosine arylamine
adducts do not result in base-substitution rever-
sions. Comparison of the adducts formed from N-
hydroxy-2-naphthylamine with the other N-hydroxy-
arylamines revealed two fundamental differences:
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N-hydroxy-2-napththylamine formed a N5-deoxy-
adenosine adduct and a ring-opened C8-deoxyguano-
sine DNA adduct. Further experimentation will be
necessary to determine whether one or both of
these particular lesions may be responsible for the
base-substitution reversions.
Conclusions
A model has been proposed for arylamine-in-
duced bladder carcinogenesis in which initial N-oxi-
dation and N-glucuronidation occur in the liver. The
conjugate is then transferred to the bladder where
under slightly acid conditions it is hydrolyzed to
yield an electrophilic N-hydroxyarylamine. To inves-
tigate this hypothesis, N-hydroxyarylamines were
incubated with DNA at slightly acidic pH and the
DNA adducts were identified. With the exception of
N-hydroxyl-1-naphthylamine, the predominant ad-
duct from each N-hydroxyarylamine was substi-
tuted through C8 of deoxyguanosine. The same
pattern of DNA adducts was observed in bladder
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FIGURE 7. Revertants/106 surviving cells and percent sur-
vival of Salmonella typhimurium TA 1535 exposed to dif-
ferent concentrations of N-hydroxyarylamines. See Figure
3 for abbreviations used.
epithelium DNA of dogs administered the parent
arylamines and in Salmonelkl typhimurium in-
cubated with their N-hydroxy derivatives. Although
a great difference in mutagenic efficiency was
detected between the various C8-deoxyguanosine
adducts, substitution at this position was associated
with frameshift mutations in Salmonellk typhi
murium TA 1538. These data suggest that N-
hydroxyarylamines are ultimate bladder carcino-
gens and that C8-deoxyguanosine substitution may
represent an initiating lesion in bladder tumor
formation.
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